Elshorbagy, Lyons, A., Vallejo-Vaz, A. R. M., Stevens, A. J., Dharmayat, C. A. T., Brandts, K. I., . . . K, K. (2024). Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: A worldwide cross-sectional study. LANCET DIABETES & ENDOCRINOLOGY, 12(11), . https://doi.org/10.1016/S2213-8587(24)00221-3
Chicago Style (17th ed.) CitationElshorbagy, et al. "Association of BMI, Lipid-lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: A Worldwide Cross-sectional Study." LANCET DIABETES & ENDOCRINOLOGY 12, no. 11 (2024). https://doi.org/10.1016/S2213-8587(24)00221-3.
MLA引文Elshorbagy, et al. "Association of BMI, Lipid-lowering Medication, and Age with Prevalence of Type 2 Diabetes in Adults with Heterozygous Familial Hypercholesterolaemia: A Worldwide Cross-sectional Study." LANCET DIABETES & ENDOCRINOLOGY, vol. 12, no. 11, 2024, https://doi.org/10.1016/S2213-8587(24)00221-3.